Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

5-HT6 receptors and Alzheimer's disease.

Ramírez MJ.

Alzheimers Res Ther. 2013 Apr 22;5(2):15. doi: 10.1186/alzrt169. eCollection 2013. Review.

2.

The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia.

Nikiforuk A.

Rev Neurosci. 2014;25(3):367-82. doi: 10.1515/revneuro-2014-0005. Review.

PMID:
24501158
3.

5-HT6 receptor memory and amnesia: behavioral pharmacology--learning and memory processes.

Meneses A, Pérez-García G, Ponce-Lopez T, Castillo C.

Int Rev Neurobiol. 2011;96:27-47. doi: 10.1016/B978-0-12-385902-0.00002-4. Review.

PMID:
21329783
4.

5-HT(6) receptor and cognition.

Codony X, Vela JM, Ramírez MJ.

Curr Opin Pharmacol. 2011 Feb;11(1):94-100. doi: 10.1016/j.coph.2011.01.004. Epub 2011 Feb 15. Review.

PMID:
21330210
5.

5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease.

Upton N, Chuang TT, Hunter AJ, Virley DJ.

Neurotherapeutics. 2008 Jul;5(3):458-69. doi: 10.1016/j.nurt.2008.05.008. Review.

PMID:
18625457
6.

Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative.

Meneses A.

Rev Neurosci. 2014;25(3):325-56. doi: 10.1515/revneuro-2014-0001. Review.

PMID:
24698823
7.

The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease.

Geldenhuys WJ, Van der Schyf CJ.

Expert Rev Neurother. 2009 Jul;9(7):1073-85. doi: 10.1586/ern.09.51. Review.

PMID:
19589055
8.

Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.

Heal DJ, Smith SL, Fisas A, Codony X, Buschmann H.

Pharmacol Ther. 2008 Feb;117(2):207-31. Epub 2007 Oct 30. Review.

PMID:
18068807
9.

Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease.

Wicke K, Haupt A, Bespalov A.

Expert Opin Investig Drugs. 2015;24(12):1515-28. doi: 10.1517/13543784.2015.1102884. Epub 2015 Nov 7.

PMID:
26548316
10.

Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity.

Gravius A, Laszy J, Pietraszek M, Sághy K, Nagel J, Chambon C, Wegener N, Valastro B, Danysz W, Gyertyán I.

Behav Pharmacol. 2011 Apr;22(2):122-35. doi: 10.1097/FBP.0b013e328343d804.

PMID:
21301322
11.

Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.

Benhamú B, Martín-Fontecha M, Vázquez-Villa H, Pardo L, López-Rodríguez ML.

J Med Chem. 2014 Sep 11;57(17):7160-81. doi: 10.1021/jm5003952. Epub 2014 Jun 3. Review.

PMID:
24850589
12.

5-HT6 receptors: a novel target for cognitive enhancement.

Mitchell ES, Neumaier JF.

Pharmacol Ther. 2005 Dec;108(3):320-33. Epub 2005 Jul 7. Review.

PMID:
16005519
13.

Computational approaches to the design of novel 5-HT6 R ligands.

Ivanenkov YA, Majouga AG, Veselov MS, Chufarova NV, Baranovsky SS, Filkov GI.

Rev Neurosci. 2014;25(3):451-67. doi: 10.1515/revneuro-2014-0030. Review.

PMID:
24867282
14.

Serotonin receptors of type 6 (5-HT6): what can we expect from them?

Marazziti D, Baroni S, Catena Dell'Osso M, Bordi F, Borsini F.

Curr Med Chem. 2011;18(18):2783-90. Review.

PMID:
21649582
15.

Signalling pathways associated with 5-HT6 receptors: relevance for cognitive effects.

Marcos B, Cabero M, Solas M, Aisa B, Ramirez MJ.

Int J Neuropsychopharmacol. 2010 Jul;13(6):775-84. doi: 10.1017/S146114570999054X. Epub 2009 Sep 9.

PMID:
19737440
16.

An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning.

Lindner MD, Hodges DB Jr, Hogan JB, Orie AF, Corsa JA, Barten DM, Polson C, Robertson BJ, Guss VL, Gillman KW, Starrett JE Jr, Gribkoff VK.

J Pharmacol Exp Ther. 2003 Nov;307(2):682-91. Epub 2003 Sep 15.

17.

A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory.

King MV, Marsden CA, Fone KC.

Trends Pharmacol Sci. 2008 Sep;29(9):482-92. Review.

PMID:
19086256
18.

Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology.

Marazziti D, Baroni S, Borsini F, Picchetti M, Vatteroni E, Falaschi V, Catena-Dell'Osso M.

Curr Med Chem. 2013;20(3):371-7. Review.

PMID:
23157629
19.

Role of serotonin in Alzheimer's disease: a new therapeutic target?

Geldenhuys WJ, Van der Schyf CJ.

CNS Drugs. 2011 Sep 1;25(9):765-81. doi: 10.2165/11590190-000000000-00000. Review.

PMID:
21870888
20.

Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat.

Marcos B, Chuang TT, Gil-Bea FJ, Ramirez MJ.

Br J Pharmacol. 2008 Oct;155(3):434-40. doi: 10.1038/bjp.2008.281. Epub 2008 Jul 14.

Items per page

Supplemental Content

Write to the Help Desk